Just 6 months since its launch, SCOUT Project Manager, Brian McFerran is incredibly pleased with the level of interest and engagement being generated within the Scottish SME community. SCOUT is a free service which aims to accelerate and de-risk the growth of Scottish SMEs in life sciences, biochemical and chemical supply chain sectors, seeking or developing disruptive technologies. Brian said, “Having built a great team across...
Mark Cook, Medtronic Mark Cook is co-Chair of the ILG and continues to support decision making for non-medicine technologies through membership of the Scottish Health Technology Group Council. Mark has spent 25 years in roles within the health sector including biologicals/pharmaceuticals, medical technology and consultancy. His current role within Medtronic includes determining the direction in areas such as strategy, government relations policy plus working specifically...
This year’s national Life Sciences conference, which will be held virtually on December 3rd, will see the launch of the Scottish Life Sciences Covid-19 strategic response plan. Dave Tudor and Ivan McKee MSP, co-chairs of the Life Sciences Industry Leadership Group, will announce the key themes of the strategy that will build on the sector’s remarkable response to Covid-19 so that patients have access to...
Clear Surgical secures £280,000 to develop portfolio of surgical device technology and to scale its groundbreaking OpLight™ technology Company is first client of new Medical Device Manufacturing Centre at Heriot Watt University Clear Surgical, an ambitious Scottish based medical device business, has secured £280,000 of new investment from existing shareholders, in an oversubscribed funding round. Led by the investment syndicate Kelvin Capital, and with Scottish...
MediCity Glasgow, a multi-agency supported incubator & accelerator project, has helped create 70 new life sciences and med-tech companies in the last five years, according to figures announced today. The project’s success includes 201 new jobs generated within Scotland’s thriving life sciences sector, coupled with over £26 M raised in private investment, against a project goal of just £5 M at its outset. The MediCity...
NovaBiotics, the clinical stage antimicrobials drug discovery company, announces that it has secured £1 million in funding from Innovate UK, allowing the company to commence clinical studies for Nylexa® a potentially game-changing therapy for the treatment of COVID-19. Nylexa has a unique dual action by targeting both the infection and hyperinflammation which are the causes of morbidity and mortality in COVID-19. Furthermore, Nylexa also acts...
In his second parliamentary statement on the response of Scotland’s businesses to Covid-19, Ivan McKee MSP, the Minister for Trade, Investment and Innovation, explained how life sciences companies in Scotland specifically, are supporting the Covid-19 effort, giving Parliament a flavour of the ability and strengths of the sector. The sector has achieved, on average, year-on-year growth of 10 per cent since 2010 and has contributed...
Symbiosis Pharmaceutical Services (Symbiosis), a fast-growing contract manufacturing organisation (CMO) specialising in sterile manufacture of vaccines, pharmaceuticals and biopharmaceuticals, and headquartered in Stirling, UK, has appointed Mr. John McCormick as chief operating officer (COO) and executive member of its Board of Directors. Previously operations development director at Symbiosis, Mr. McCormick has 15 years of experience in the pharmaceutical and biotechnology industry in various roles including...
Deal to create 200 new jobs as UK unemployment soars. At a briefing on 13th August, the First Minister for Scotland, Nicola Sturgeon, announced that British PPE supplier Alpha Solway, part of the Globus Group, has been selected to manufacture 232 million surgical masks and 2 million visors for NHS Scotland. The £53 million order will meet the demand for Scotland’s health and social care...
Valneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, today confirmed its participation in the UK government COVID-19 vaccine response program. Valneva has reached agreement in principle with the UK government to provide up to 100 million doses of its SARS-CoV-2 vaccine candidate, to be manufactured at its facilities in Livingston, Scotland. The UK government is expected to contribute...